Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1979 2
1980 1
1981 4
1982 6
1983 9
1984 11
1985 8
1986 5
1987 4
1988 12
1989 12
1990 50
1991 70
1992 81
1993 111
1994 158
1995 167
1996 223
1997 210
1998 229
1999 276
2000 303
2001 326
2002 346
2003 384
2004 344
2005 420
2006 400
2007 406
2008 439
2009 465
2010 484
2011 494
2012 556
2013 620
2014 658
2015 657
2016 710
2017 657
2018 598
2019 640
2020 622
2021 586
2022 236
Text availability
Article attribute
Article type
Publication date

Search Results

11,860 results
Results by year
Filters applied: . Clear all
Page 1
A global view of hepatocellular carcinoma: trends, risk, prevention and management.
Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. Yang JD, et al. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31439937 Free PMC article. Review.
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol addiction, metabolic liver disease (particularly nonalcoholic fatty liver …
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include …
Natural history of hepatitis C.
Westbrook RH, Dusheiko G. Westbrook RH, et al. J Hepatol. 2014 Nov;61(1 Suppl):S58-68. doi: 10.1016/j.jhep.2014.07.012. Epub 2014 Nov 3. J Hepatol. 2014. PMID: 25443346 Free article. Review.
There has long been evidence that hepatitis C can lead to persistent infection in a high proportion of infected individuals, and can progress to chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC). The transition from acute to chronic hepatitis
There has long been evidence that hepatitis C can lead to persistent infection in a high proportion of infected individuals, a …
Current epidemiology in hepatocellular carcinoma.
Konyn P, Ahmed A, Kim D. Konyn P, et al. Expert Rev Gastroenterol Hepatol. 2021 Nov;15(11):1295-1307. doi: 10.1080/17474124.2021.1991792. Epub 2021 Oct 22. Expert Rev Gastroenterol Hepatol. 2021. PMID: 34624198 Review.
INTRODUCTION: Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-leading cause of cancer-related mortality in the world. ...With the introduction of direct-acting antiviral agents for hepatitis C virus infection, routin …
INTRODUCTION: Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-leading cause of cancer-rela …
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. de Martel C, et al. Lancet Glob Health. 2020 Feb;8(2):e180-e190. doi: 10.1016/S2214-109X(19)30488-7. Epub 2019 Dec 17. Lancet Glob Health. 2020. PMID: 31862245 Free article.
BACKGROUND: Infectious pathogens are strong and modifiable causes of cancer. The aim of this study was to improve estimates of the global and regional burden of infection-attributable cancers to inform research priorities and facilitate prevention efforts. .. …
BACKGROUND: Infectious pathogens are strong and modifiable causes of cancer. The aim of this study was to improve estimates of …
Diet and liver cancer risk: a narrative review of epidemiological evidence.
Yang WS, Zeng XF, Liu ZN, Zhao QH, Tan YT, Gao J, Li HL, Xiang YB. Yang WS, et al. Br J Nutr. 2020 Aug 14;124(3):330-340. doi: 10.1017/S0007114520001208. Epub 2020 Apr 1. Br J Nutr. 2020. PMID: 32234090 Review.
Primary liver cancer is the third leading cause of cancer-related death worldwide. Most patients are diagnosed at late stages with poor prognosis; thus, identification of modifiable risk factors for primary prevention of liver cancer is urgently needed …
Primary liver cancer is the third leading cause of cancer-related death worldwide. Most patients are diagnosed at late …
Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Rizvi S, Gores GJ. Rizvi S, et al. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. Gastroenterology. 2013. PMID: 24140396 Free PMC article. Review.
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomically as intrahepatic CCA (iCCA), perihilar CCA (pCCA), or distal CCA. These subtypes differ not only in their anatomic location, but in epide …
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomica …
Hepatitis C virus associated hepatocellular carcinoma.
Khatun M, Ray R, Ray RB. Khatun M, et al. Adv Cancer Res. 2021;149:103-142. doi: 10.1016/bs.acr.2020.10.003. Epub 2020 Nov 16. Adv Cancer Res. 2021. PMID: 33579422 Review.
Liver cancer is a global problem and hepatocellular carcinoma (HCC) accounts for about 85% of this cancer. In the USA, etiologies and risk factors for HCC include chronic hepatitis C virus (HCV) infection, diabetes, non-alcoholic steatohepatitis (NASH) …
Liver cancer is a global problem and hepatocellular carcinoma (HCC) accounts for about 85% of this cancer. In the USA, etiolog …
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.
Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Fujiwara N, et al. J Hepatol. 2018 Mar;68(3):526-549. doi: 10.1016/j.jhep.2017.09.016. Epub 2017 Oct 6. J Hepatol. 2018. PMID: 28989095 Free PMC article. Review.
Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies, are at a high risk of developing hepatocellular carcinoma (HCC). ...Furthermore, optimal screening strategies for emerging at-risk patient populations, such as those with chronic …
Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies, are at a high risk of developing hepat …
Increased cancer rates in patients with chronic hepatitis C.
Nyberg AH, Sadikova E, Cheetham C, Chiang KM, Shi JX, Caparosa S, Younossi ZM, Nyberg LM. Nyberg AH, et al. Liver Int. 2020 Mar;40(3):685-693. doi: 10.1111/liv.14305. Epub 2019 Dec 22. Liver Int. 2020. PMID: 31755208
AIMS: As previous reports show an association of chronic hepatitis C (HCV) with hepatocellular carcinoma (HCC) and non-liver cancers, we examine the association of HCV with liver cancer and non-liver cancers. ...After stratification for alcohol …
AIMS: As previous reports show an association of chronic hepatitis C (HCV) with hepatocellular carcinoma (HCC) and non-liver …
The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer.
Shiani A, Narayanan S, Pena L, Friedman M. Shiani A, et al. Cancer Control. 2017 Jul-Sep;24(3):1073274817729240. doi: 10.1177/1073274817729240. Cancer Control. 2017. PMID: 28975833 Free PMC article. Review.
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Underlying chronic liver disease has been associated with an increased risk of developing HCC. ...Hepatitis C virus, hepatitis B virus (HBV), nonalcoho …
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Underlying chronic liver disease …
11,860 results
You have reached the last available page of results. Please see the User Guide for more information.